Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182 (Q30360249)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182 (English)

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

1 reference

based on heuristic

inferred from title

author name string

Neil S Horowitz

1

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Austin Miller

2

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Bunja Rungruang

3

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Scott D Richard

4

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Noah Rodriguez

5

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Michael A Bookman

6

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Chad A Hamilton

7

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Thomas C Krivak

8

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

G Larry Maxwell

9

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

language of work or name

0 references

publication date

9 February 2015

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

33

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

8

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

937-943

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Disparities in ovarian cancer care quality and survival according to race and socioeconomic status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

3 June 2018

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

3 June 2018

The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

3 June 2018

Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

3 June 2018

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

3 June 2018

Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

3 June 2018

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

3 June 2018

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

3 June 2018

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

3 June 2018

Maternal pesticide exposure from multiple sources and selected congenital anomalies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

3 June 2018

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

3 June 2018

Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

26 November 2018

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

26 November 2018

The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

26 November 2018

Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

26 November 2018

Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4348639

26 November 2018

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25667285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays

1 reference

https://pubmed.ncbi.nlm.nih.gov/25667285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25667285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25667285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Causal diagrams for epidemiologic research

1 reference

https://pubmed.ncbi.nlm.nih.gov/25667285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25667285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25667285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25667285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25667285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

1 reference

https://pubmed.ncbi.nlm.nih.gov/25667285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/25667285

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2014.56.3106

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30360249&oldid=1550147921"